Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NeuroRx financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.3
2024-10-29
Market Capitalization
$13.7 M
2024-10-29
Revenue
$1.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2M | ||||||||
| Cost of goods sold | 505.0K | ||||||||
| Gross profit | 720.0K | ||||||||
| Gross profit margin, % | 58.8% | ||||||||
| General and administrative expense | 74.9M | 27.3M | 14.2M | 13.5M | 13.1M | ||||
| Operating expense total | 95.2M | 44.3M | 27.6M | 19.7M | 16.9M | ||||
| Depreciation and amortization | 80.0K | ||||||||
| EBIT | (134.5K) | (1.0M) | (713.2K) | (907.4K) | (115.8M) | (44.3M) | (27.8M) | (18.5M) | (16.2M) |
| EBIT margin, % | -1324.4% | ||||||||
| Interest income | 249.0K | 494.0K | 44.0K | 12.0K | |||||
| Interest expense | 34.2K | 1.1M | 1.2M | 138.8K | 18.0K | 120.0K | 374.0K | ||
| Pre tax profit | 82.4K | 492.6K | (416.6K) | (93.1M) | (39.8M) | ||||
| Income tax expense | 16.3K | 84.2K | 17.8K | ||||||
| Net Income | (105.0K) | 66.1K | 408.4K | (434.4K) | (93.1M) | (39.8M) | (30.1M) | (25.1M) | |
| EPS | (2.0) | (0.6) |